Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Di Nicolantonio
Aldo Di Nicolantonio, Recherswil CH
| Patent application number | Description | Published |
|---|---|---|
| 20090321102 | HAND-HELD POWER TOOL - The invention relates to a hand tool ( | 12-31-2009 |
| 20100005629 | AUXILIARY HANDLE DEVICE - The invention is based on an auxiliary handle device, in particular for hand-held power tools, comprising a fastening unit which comprises at least one fastening mechanism. It is proposed that the fastening mechanism is provided in an axial direction of a fastening axis in order to achieve a positive connection. | 01-14-2010 |
| 20100163264 | HAND-HELD POWER TOOL - The invention relates to a hand-held tool ( | 07-01-2010 |
| 20110271814 | Guide Rail for a Hand-held Power Tool - A guide rail for a hand-held power tool includes at least two rail elements, which are to be joined together to form a common rail and which are held on one another by means of a releasable connecting device. The connecting device includes a joint device, by means of which the individual rails can be pivoted between a folded-together non-functioning position and a functioning position that lies in a common plane. | 11-10-2011 |
Arthur R. Di Nicolantonio, Seabrook, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080221378 | Apparatus and Process for Cracking Hydrocarbonaceous Feed Utilizing a Pre-Quenching Oil Containing Crackable Components - An apparatus and process are provided for cracking hydrocarbons. Hot, cracked effluent is removed to a quench header where it is pre-quenched with an oil containing crackable components, e.g., 1000° F. | 09-11-2008 |
| 20090050530 | Process and Apparatus for Steam Cracking Hydrocarbon Feedstocks - The present disclosure provides a process for treating a hydrocarbon feedstock comprising: (a) feeding the hydrocarbon feedstock at a linear velocity equal to or less than 0.9 m/s to a first preheating zone in the convection section of a steam cracking furnace; (b) preheating the hydrocarbon feedstock in the first preheating zone to vaporize less than 99 wt. % of the hydrocarbon feedstock to form a vapor-liquid mixture; (c) separating at least a portion of the vapor-liquid mixture to form a vapor fraction and a liquid fraction; and (d) feeding at least a portion of the vapor fraction to the steam cracking furnace. | 02-26-2009 |
Federica Di Nicolantonio, La Loggia (torino) IT
| Patent application number | Description | Published |
|---|---|---|
| 20090269344 | Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues - The invention relates to an indidualized and personalized diagnosis and therapy of cancer based on specific molecular alterations which occur in specific tumor tissue of specific tumor patient populations. The therapy and diagnostic is based on the findings that proliferation and tumor growth of specific EGFR bearing tumor tissue expressing an amplified EGFR gene copy number may be abolished by anti-EGFR antibodies, while other individual molecular alterations such as mutations occurring in tumor tissues are unaffected by the same anti-EGFR antibody treatment. | 10-29-2009 |
Federica Di Nicolantonio, La Loggia (to) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120115896 | ISOGENIC HUMAN CELL LINES COMPRISING MUTATED CANCER ALLELES AND PROCESS USING THE CELL LINES - Isogenic human cell lines comprising at least one mutated cancer allele under the control of the cell line endogenous promoter, which corresponds to the wild-type cancer allele promoter are disclosed, as well as an in vitro process for determining sensitivity/resistance of a patient suffering from a tumor to a pharmacological agent comprising the following steps: a) identifying at least one mutated cancer allele in a tissue affected by a tumor of said patient; b) providing an isogenic human cell line representative of the tissue, wherein the cell line comprises at least the identified mutated cancer allele, which is under the control of the cell line endogenous promoter corresponding to the wild-type cancer allele promoter; c) putting in contact said cell line with the pharmacological agent; d) determining a variation of proliferation, apoptosis or cytotoxicity of the cell line in presence of the pharmacological agent; wherein the variation of proliferation, apoptosis car cytotoxicity indicative of the sensitivity/resistance of the patient tumor to the pharmacological agent. | 05-10-2012 |